Top 10 Undervalued Stocks To Own For 2019

&l;p&g;&l;img class=&q;dam-image bloomberg size-large wp-image-42435712&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/42435712/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Bloomberg

The NASDAQ is generally not thought of as home sweet home for value stocks. Typically, if you&s;re looking at a NASDAQ situation, you&s;re looking for growth.&a;nbsp; But if you&s;re willing to take a deep dive sometimes you can find interesting potential candidates just under the growth-oriented surface. Are companies trading there which might still be thought of as &q;undervalued?&q;

I found this group that might fit by screening for those with price/earnings ratios of below 15 and which are trading for less than book value. Anything that failed to show positive earnings over the past half-decade is ignored. With all of that in mind and acknowledging that there may be significant issues underlying such stocks, here&s;s the list of those that fit the basic requirements:

Top 10 Undervalued Stocks To Own For 2019: PDC Energy, Inc.(PDCE)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PDC Energy (PDCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    News articles about PDC Energy (NASDAQ:PDCE) have trended somewhat positive this week, Accern reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PDC Energy earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the energy producer an impact score of 46.6251700229584 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PDC Energy (PDCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Own For 2019: Genfit SA (GNFTF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    In a recent article, we discussed what makes Genfits (OTCPK:GNFTF) Elafibranor one of the most promising candidates in the NASH treatment development space. Given the unmet need (no approved therapies), Elafibranors mechanism of action and the potential it has shown in clinical stages, we see a strong chance of approval if the pivotal Phase 3 study succeeds. In this article, we will briefly discuss the chances of Elafibranors success in clinical stages and Genfits valuation based on the potential of its lead product candidate. We will briefly also discuss the risks to the investment thesis.

  • [By ]

    This phase 2 data for Madrigal was phenomenal, which is why I think it will do well in a phase 3 trial. The other side of the trade is that Intercept Pharmaceuticals (ICPT) and Genfit (OTCPK:GNFTF) are further along with phase 3 trials, which are expected to read out NASH results by 2019/2020. Intercept has a good drug with Ocaliva, however, it suffers from toxicity issues when Doctors prescribe higher than necessary dosing. On the flip side, Ocaliva has shown a greater difference in fibrosis reduction for NASH in its phase 2 FLINT trial compared to MGL-3196. What do I mean by that? Well, as you can see above MGL-3196 obtained a fibrosis reduction in NASH patients of 29% compared to 23% for those on placebo creating a difference of only 6%. If you look at Ocaliva from the FLINT trial, from Intercept Pharmaceuticals, it had a fibrosis reduction of 35% compared to 19% of those NASH patients on placebo. It is just something to keep in mind. I still believe that MGL-3196 will eventually be approved. The question that should be asked is how well will it do compared to other competitors in the same space with better fibrosis reductions? That will be key, because NASH causes fibrosis (scarring) of the liver. Fibrosis eventually turns into cirrhosis of the liver, which can eventually lead to liver failure. That’s why, in my opinion, a drug that will have the most impact on NASH will be one that shows a major reduction in fibrosis. The good news is that the NASH market is expected to reach between $20 to $30 billion in the coming years. It is a large market for plenty of players in this space. The other endpoints are important as well, but in a competitive market such as NASH, fibrosis reduction will make the difference in terms of more sales. This is just an important factor to keep in mind.

  • [By ]

    Heres what we wrote: With GR-MD-02, Galectin is also targeting a different spectrum of NASH. The companys programs with GR-MD-02 are focusing on NASH treatment in individuals with advanced fibrosis and cirrhosis. As we mentioned before, Genfit (OTCPK:GNFTF) and Intercept (ICPT) are targeting what can be termed as the sweet spot of the NASH spectrum. Galecctin is one of the few companies targeting advanced stage of the disease. This makes it both an interesting and at the same time risky bet in the NASH space.

Top 10 Undervalued Stocks To Own For 2019: Cabot Microelectronics Corporation(CCMP)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Cabot Microelectronics Co. (NASDAQ:CCMP) have received a consensus recommendation of “Buy” from the seven research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $114.80.

  • [By Ethan Ryder]

    Shares of Cabot Microelectronics Co. (NASDAQ:CCMP) have earned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $112.25.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Cabot Microelectronics (CCMP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Cabot Microelectronics (NASDAQ: CCMP) and Analog Devices (NASDAQ:ADI) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, earnings and dividends.

  • [By Joseph Griffin]

    News coverage about Cabot Microelectronics (NASDAQ:CCMP) has been trending somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cabot Microelectronics earned a daily sentiment score of 0.03 on Accern’s scale. Accern also gave news stories about the semiconductor company an impact score of 46.640513544039 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Top 10 Undervalued Stocks To Own For 2019: Templeton Dragon Fund Inc.(TDF)

Advisors’ Opinion:

  • [By Shane Hupp]

    Templeton Dragon Fund Inc common stock (NYSE:TDF) major shareholder City Of London Investment Grou bought 8,155 shares of the company’s stock in a transaction that occurred on Tuesday, June 12th. The shares were purchased at an average price of $22.87 per share, with a total value of $186,504.85. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Top 10 Undervalued Stocks To Own For 2019: Forward Pharma A/S(FWP)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Forward Pharma A/S (NASDAQ: FWP) shares gained 88.18 percent to close at $4.14 on Tuesday.
    Regional Health Properties, Inc. (NYSE: RHE) shares jumped 18.04 percent to close at $0.3010 on Tuesday.
    Precipio, Inc. (NASDAQ: PRPO) shares gained 16.61 percent to close at $0.49 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.
    Arcturus Therapeutics Ltd. (NASDAQ: ARCT) rose 16.09 percent to close at $7.00 on Tuesday.
    America's Car-Mart, Inc. (NASDAQ: CRMT) gained 14.53 percent to close at $62.65 after reporting upbeat Q4 results.
    NanoString Technologies, Inc. (NASDAQ: NSTG) shares surged 12.64 percent to close at $13.19.
    Geron Corporation (NASDAQ: GERN) gained 12.12 percent to close at $4.07 on Tuesday.
    Quotient Limited (NASDAQ: QTNT) shares climbed 11.58 percent to close at $6.55 on Tuesday.
    American Equity Investment Life Holding Company (NYSE: AEL) rose 11.23 percent to close at $32.28 following a report from Reuters that the company is looking for a sale.
    iQIYI, Inc. (NASDAQ: IQ) gained 11.15 percent to close at $22.52.
    Veracyte, Inc. (NASDAQ: VCYT) rose 10.4 percent to close at $7.11.
    Stein Mart, Inc. (NASDAQ: SMRT) gained 10.26 percent to close at $3.33. Stein Mart is expected to release quarterly earnings on May 23.
    MiMedx Group, Inc. (NASDAQ: MDXG) shares rose 10.11 percent to close at $8.06.
    The Container Store Group, Inc. (NYSE: TCS) gained 8.2 percent to close at $8.18. Container Store reported weaker-than-expected earnings for its fourth quarter after the closing bell.
    Photronics, Inc. (NASDAQ: PLAB) shares gained 7.69 percent to close at $9.10 after the company reported upbeat Q2 results.
    Micron Technology, Inc. (NASDAQ: MU) rose 6.4 percent to close at $59.03 after reporting a $10 billion buyback plan.

     

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Forward Pharma A/S (NASDAQ: FWP) fell 15.2 percent to $3.51 in pre-market trading after surging 88.18 percent on Tuesday.
    Pfenex Inc. (NASDAQ: PFNX) shares fell 15 percent to $5.85 in pre-market trading after the company announced an offering of common stock.
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) fell 17.6 percent to $47.75 in pre-market trading after the company reported downbeat results for its first quarter and issued a weak earnings forecast for the second quarter.
    Container Store Group, Inc. (NYSE: TCS) fell 13 percent to $7.15 in pre-market trading after reporting weaker-than-expected earnings for its fourth quarter.
    Ardelyx, Inc. (NASDAQ: ARDX) shares fell 12.1 percent to $4.00 in pre-market trading after reporting pricing of public offering of common stock.
    Boston Scientific Corporation (NYSE: BSX) shares fell 9.8 percent to $27.31 in pre-market trading.
    Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) fell 6.5 percent to $6.60 in pre-market trading.
    Target Corporation (NYSE: TGT) shares fell 5.8 percent to $71.02 in pre-market trading. Target reported weaker-than-expected earnings for its first quarter, while sales exceeded estimates.
    PBF Energy Inc. (NYSE: PBF) shares fell 5.7 percent to $42.42 in pre-market trading

Top 10 Undervalued Stocks To Own For 2019: Microsoft Corporation(MSFT)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Earnings season is well underway. And if you’re looking to make real money, the time to get started is now. Money MorningQuantitative Specialist Chris Johnson argues the markets are at a tipping point. And with just a few smart plays in today’s classic stock picker’s market… you can pull in triple-digit gains with just a small investment. Read those picks right here.

    The Top Stock Market Stories for Thursday
    This morning, the U.S. Department of Labor said that weekly jobless claims came in at 207,000 for the week. That figure is below the 220,000 jobless claims expected by economists and brings U.S. unemployment claims to a 48.5-year low. It’s a big day of earnings reports, as dozens of blue chip companies will report results from the June-ending quarter. The biggest name today will be Microsoft Corp.(Nasdaq: MSFT), which reports earnings after the bell. Wall Street expects that the technology giant will report earnings of $1.07 per share. Analysts project quarterly revenue of $29.17 billion.
    Three Stocks to Watch Today: PM, IBM, AA
    International Business Machines (NYSE: IBM) stock added 2.5% in pre-market hours after Big Blue topped Wall Street earnings and revenue expectations. The tech giant continues to post positive results as it accelerates its turnaround efforts. IBM reported earnings per share of $3.08, a figure that beat estimates by $0.04 per share. It also reported quarterly revenue of $20.0 billion, a figure that surpassed estimates of $19.85 billion. Shares of Alcoa Corp. (NYSE: AA) fell 2% this morning. The aluminum manufacturer slashed its 2018 outlook due to falling prices and the recent round of metals tariffs introduced by the Trump administration. But there could be more pain in sight. Today, the U.S. Justice Department will hold a hearing that aims to determine whether vehicle and light truck imports present a national security threat to the United States. The hearing is due to President Trump’s pledge to hit European auto man

  • [By Money Morning News Team]

    This ETF holds shares of 30 stocks that are major players in the cloud computing market. Chief among them is Amazon.com Inc. (Nasdaq: AMZN), who leads all other cloud services with its AWS service. Another is Microsoft Corp. (Nasdaq: MSFT), whose Azure cloud service is now the second largest of its kind in the world.

  • [By Max Byerly]

    Microsoft (NASDAQ:MSFT) has been given a $125.00 target price by analysts at Credit Suisse Group in a research report issued on Friday. The firm currently has a “buy” rating on the software giant’s stock. Credit Suisse Group’s price objective suggests a potential upside of 17.62% from the company’s previous close.

  • [By Chuck Saletta]

    As Amazon CEO Jeff Bezos famously said, “Your margin is my opportunity.”Amazon’s own margin is coming from computing services — an area where it faces stiff competition from the likes of Microsoft (NASDAQ:MSFT). Microsoft is no stranger to aggressive competitive practices, and it doesn’t have to support a massive retail business with the revenue from cloud computing.

  • [By JJ Kinahan]

    In addition to reports from T and VZ, these are some of the other major companies reporting earnings this week:

    Caterpillar Inc. (NYSE: CAT) and Eli Lilly and Co. (NYSE: LLY) report before market open on Tuesday, Apr. 24
    Boeing Co (NYSE: BA) reports before the open on Wednesday, Apr. 25
    Twitter Inc. (NYSE: TWTR) reports before the open Wednesday, Apr. 25 and Facebook, Inc. (NASDAQ: FB) reports after the close the same day
    Ford Motor Company (NYSE: F) reports after market close Wednesday, Apr. 25 and General Motors Company (NYSE: GM) reports before the open Thursday, Apr. 26
    Amazon.com, Inc. (NASDAQ: AMZN), Intel Corporation (NASDAQ: INTC) and Microsoft Corporation (NASDAQ: MSFT) all report after market close Thursday, Apr. 26
    Chevron Corporation (NYSE: CVX) and Exxon Mobil Corporation (NYSE: XOM) report before the open Friday, Apr. 27

    Information from TDA is not intended to be investment advice or construed as a recommendation or endorsement of any particular investment or investment strategy, and is for illustrative purposes only. Be sure to understand all risks involved with each strategy, including commission costs, before attempting to place any trade.

  • [By WWW.GURUFOCUS.COM]

    For the details of Milestone Resources Group Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Milestone+Resources+Group+Ltd

    These are the top 5 holdings of Milestone Resources Group LtdAccenture PLC (ACN) – 762,770 shares, 13.26% of the total portfolio. Microsoft Corp (MSFT) – 1,100,825 shares, 11.54% of the total portfolio. Shares reduced by 8.69%Alphabet Inc (GOOGL) – 92,032 shares, 11.04% of the total portfolio. Shares reduced by 9.52%S&P Global Inc (SPGI) – 463,802 shares, 10.05% of the total portfolio. Zoetis Inc (ZTS) – 1,065,914 shares, 9.6

Top 10 Undervalued Stocks To Own For 2019: Pain Therapeutics(PTIE)

Advisors’ Opinion:

  • [By Chris Lange]

    Pain Therapeutics Inc. (NASDAQ: PTIE) shares were destroyed on Wednesday after a vote from the U.S. Food and Drug Administration (FDA) was announced. As we have said before, the FDA has the potential to make or break biopharmaceutical companies. In this case, Pain Therapeutics has been broken.

  • [By Brian Orelli]

    DURECT Corp. (NASDAQ:DRRX) is down 9.2% at 12:45 p.m. EDT after the U.S. Food and Drug Administration’s advisory committee voted14 to 3 recommending the agency not approve Remoxy ER, an abuse-deterrent extended-release pain medication being developed by its partner Pain Therapeutics(NASDAQ: PTIE).

  • [By Peter Graham]

    Small cap pain stock Pain Therapeutics (NASDAQ: PTIE) has elevated short interest of 35.77% according to Highshortinterest.com. Pain Therapeuticsdevelops proprietary drugs that offer significant improvements to patients and physicians.The Companysexpertise consists of developing new drugs and guiding these through various regulatory and development pathways in preparation for their eventual commercialization with a focuson drug development efforts around disorders of the nervous system.The FDA has not yet established the safety or efficacy ofany drug candidates. Pain Therapeuticspipeline of drug assets includes:

Top 10 Undervalued Stocks To Own For 2019: International Speedway Corporation(ISCA)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    International Speedway Corporation (NASDAQ: ISCA)Q2 2018 Earnings Conference callJul. 05, 2018, 1:00 pm ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on International Speedway Corp Class A (ISCA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on International Speedway Corp Class A (ISCA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Own For 2019: BHP Billiton plc(BBL)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of BHP Billiton plc (NYSE:BBL) gapped down before the market opened on Thursday . The stock had previously closed at $43.47, but opened at $43.83. BHP Billiton shares last traded at $44.17, with a volume of 117112 shares.

  • [By Max Byerly]

    Natixis Advisors L.P. raised its position in shares of BHP Billiton plc (NYSE:BBL) by 10.2% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,996 shares of the mining company’s stock after purchasing an additional 1,113 shares during the quarter. Natixis Advisors L.P.’s holdings in BHP Billiton were worth $477,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Hallador Energy (NASDAQ: HNRG) and BHP Billiton (NYSE:BBL) are both oils/energy companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends.

Top 10 Undervalued Stocks To Own For 2019: VALE S.A.(VALE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of Vale SA (NYSE:VALE) gapped down before the market opened on Monday . The stock had previously closed at $13.11, but opened at $12.82. Vale shares last traded at $12.49, with a volume of 13924600 shares.

  • [By Joseph Griffin]

    Westwood Holdings Group Inc. purchased a new position in Vale SA (NYSE:VALE) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 11,796 shares of the basic materials company’s stock, valued at approximately $150,000.

  • [By Billy Duberstein]

    Wheaton’s new streaming deal is with Brazilian miner Vale (NYSE:VALE)at its Voisey Bay nickel mine in Newfoundland, Canada. Wheaton, along with smaller Canadian streaming company Cobalt 27 Capital Corp., will invest a combined $690 million in Vale’s $1.7 billion expansion of the mine. Vale’s initial plans have been delayed since last August, when the price of nickel declined; however, thanks to Wheaton and Cobalt 27, the mine will be expanded and will begin producing cobalt by 2021.

  • [By Stephan Byrd]

    State of New Jersey Common Pension Fund D increased its stake in shares of Vale (NYSE:VALE) by 12.4% in the first quarter, HoldingsChannel reports. The firm owned 781,510 shares of the basic materials company’s stock after buying an additional 86,443 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Vale were worth $9,941,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Rational Advisors LLC grew its position in Vale SA (NYSE:VALE) by 49.5% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 14,951 shares of the basic materials company’s stock after acquiring an additional 4,951 shares during the period. Rational Advisors LLC’s holdings in Vale were worth $191,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Brookfield Asset Management Inc. purchased a new position in shares of Vale SA (NYSE:VALE) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 40,493 shares of the basic materials company’s stock, valued at approximately $515,000.

Leave a Reply

Your email address will not be published. Required fields are marked *